Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Molecular Interventions|September 9, 2006
The pharmocogenomics of warfarin: closing in on personalized medicineAllan E Rettie, Guoying Tai
Pharmaceutical Research|August 31, 2013
The importance of villous physiology and morphology in mechanistic physiologically-based pharmacokinetic modelsEmile P Chen, Guoying Tai, Harma Ellens
The Journal of Pharmacology and Experimental Therapeutics|March 5, 2009
CYP2C9 amino acid residues influencing phenytoin turnover and metabolite regio- and stereochemistryCarrie M Mosher, Guoying Tai, Allan E Rettie
Drug Metabolism and Disposition: the Biological Fate of Chemicals|September 17, 2010
A mechanism-based mathematical model of aryl hydrocarbon receptor-mediated CYP1A induction in rats using beta-naphthoflavone as a tool compoundEmile P Chen, Liangfu Chen, Yan Ji, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|September 7, 2013
Impact of physiologically based pharmacokinetic modeling and simulation in drug developmentCarole E Shardlow, Grant T Generaux, Aarti H Patel, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 9, 2008
Re-engineering of CYP2C9 to probe acid-base substrate selectivityGuoying Tai, Leslie J Dickmann, Nicholas Matovic, et al.
Clinical Pharmacology in Drug Development|May 20, 2020
Pharmacokinetics of Gepotidacin in Renal ImpairmentMohammad Hossain, Courtney Tiffany, Aparna Raychaudhuri, et al.
British Journal of Clinical Pharmacology|July 21, 2021
Comparison between physiologically based pharmacokinetic and population pharmacokinetic modelling to select paediatric doses of gepotidacin in plagueDung Nguyen, Jafar Sadik Shaik, Guoying Tai, et al.
Pageof 2